Safety and Efficacy of Topical Moxifloxacin for Prevention of Post-Traumatic Endophthalmitis: Randomized Controlled Clinical Trial
Conditions: Endophthalmitis; Open Globe Injury; Moxifloxacin; Post-Traumatic Endophthalmitis Interventions: Drug: Moxifloxacin Ophthalmic 0.5% Ophthalmic Solution; Drug: Ciprofloxacin 400 MG/200 ML Intravenous Solution [CIPRO IV] Sponsor: University of Campinas, Brazil Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Avelox | Brazil Health | Cipro | Ciprofloxacin | Clinical Trials | Moxifloxacin | Opthalmology | Post Traumatic Stress Disorder | Research